Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Centene Corp (NY: CNC )

73.40 +1.40 (+1.94%)
Streaming Delayed Price Updated: 2:04 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Centene Corp

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Recap: Centene Q1 Earnings
Centene (NYSE:CNC) reported its Q1 earnings results on Tuesday, April 26, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For April 26, 2022
Companies Reporting Before The Bell • First American Financial (NYSE:FAF) is estimated to report quarterly loss at $0.09 per share on revenue of $46.41 million. 
Via Benzinga
What Centene’s Next Era in Managed Care Looks Like
New Centene CEO Sarah London faces pressure from activists to increase profits, and from government to deliver more care. 
Via InvestorPlace
Biden To Propose Change To Obamacare To Extend Subsidies For Families: WSJ
Via Benzinga
House Passes Bill To Cap Out-of-Pocket Insulin Costs To No More Than $35/Month
The House of Representatives voted to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare.  
Via Benzinga
Recap: Centene Q4 Earnings
  Centene (NYSE:CNC) reported its Q4 earnings results on Tuesday, February 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Analyst Ratings For Centene
Over the past 3 months, 9 analysts have published their opinion on Centene (NYSE:C... 
Via Benzinga
Expert Ratings For Centene
Analysts have provided the following ratings for Centene (NYSE:CNC) within the... 
Via Benzinga
7 Healthcare Stocks to Buy for the Long Term
When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks. 
Via InvestorPlace
Stock Market Rally Stalls As Inflation, Treasury Yields Soar: Weekly Review
The stock market rally remains stuck in a recent range as the major indexes slashed weekly gains on hot inflation. Treasury yields surged. 
Via Investor's Business Daily
Analyst Ratings For Centene
Over the past 3 months, 9 analysts have published their opinion on Centene (NYSE:CNC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
CVS Health Earnings Beat But Guidance Is Tepid; CVS Stock Slips
CVS earnings topped estimates, though guidance implies an EPS dip in 2022. 
Via Investor's Business Daily
Centene Shares Jump On Better Than Expected Q4 Earnings, Reaffirms FY22 Guidance
Centene Corporation (NYSE: CNC) has reported Q4 adjusted EPS of $1.01, 
Via Benzinga
A Peek Into The Markets: US Stock Futures Mostly Higher Ahead Of Earnings Reports
Pre-open movers 
Via Benzinga
5 Stocks To Watch For February 8, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects Pfizer Inc. (NYSE: PFE) to report quarterly earnings at $0.87 per share on revenue of $24.20 billion before the opening... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Teladoc Stock Is Due for a Major Upside Reversal
Teladoc is worth at least $110 a share assuming its revenue grows at historical rates for the next few years. 
Via InvestorPlace
Earnings Scheduled For February 8, 2022
Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion. 
Via Benzinga
5 Stocks Insiders Are Selling: Accenture, Centene And More
French CAC 40 Index gained around 1% this morning, partially recovering from previous session’s 4% plunge, as investors await the policy decision from the Federal Reserve... 
Via Benzinga
14 Stocks in the Healthcare Sector
Here are 14 companies in the Healthcare Sector that have investment-grade credit ratings of BBB- or better, cash flow yield of 6% or better, future total return of at least 5%. 
Via Talk Markets
Clover Health Stock Investors Will Need to Buy Into Tech Chief’s Vision
CTO Andrew Toy's innovations like Clover Assistant, seen by some as savior of CLOV stock, are already being adopted by larger Medicare Advantage players. 
Via InvestorPlace
5 S&P 500 Stocks Set To Report Triple-Digits Earnings Growth
Given the robust projections, most S&P 500 stocks are likely to post triple-digit earnings growth. Some of these are CF Industries, Exxon Mobil, Tesla, Centene Corporation, and Southwest Airlines. 
Via Talk Markets
Bulls Should Begin 2022 With A Win
The first trading day of the new year is seasonally very strong by a number of studies and that is reinforced by the late day weakness to end 2021. 
Via Talk Markets
Centene Corporation Climbs to Annual-High Share Price
Shares of Centene Corporation (NYSE: CNC) traded at a new 12-month high today of $85.02. So far today approximately 439,000 shares have been exchanged, as compared to an average... 
Via Benzinga
Watch for Continued Gains in Shares of Centene Corporation
Shares of Centene Corporation (NYSE: CNC) traded today at $83.08, eclipsing its 12-month high. So far today, approximately 1.7 million shares have been exchanged, as compared to... 
Via Benzinga
4 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
CNBC's Final Call: Centene, Meta Platforms, And Consumer Staples
On CNBC's "Options Action: The Final Call," Carter... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2021
Upgrades According to Wells Fargo, the prior rating for Douglas Emmett Inc (NYSE: 
Via Benzinga
Amid More Evidence of Tough Competition, Teladoc Stock Remains a Sell
Teladoc's slowing growth and increased spending indicates that its competition is increasingly tough, making TDOC stock a sell. 
Via InvestorPlace
Teledoc Stock Will Break Out with New Product Features
Teledoc’s product suite myStrength Complete and Primary 360 will enhance growth in the coming quarters and into 2023. With Teledoc's integration with Livongo's product features, the company is bound to... 
Via InvestorPlace
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.